Artículos de revistas
Terapia endovascular en el sindrome de vena cava superior: caso clínico
Autor
Boza W,Camilo
Mertens M,Renato
Valdés E,Francisco
Kramer Sch,Albrecht
Mariné M,Leopoldo
Vergara G,Jeanette
Institución
Resumen
The treatment of superior vena cava syndrome is usually oriented to the underlying cause, that can be too slow in emergency cases. We report a 49 years old woman with a multiple myeloma that was admitted due to a superior vena cava syndrome caused by a central venous catheter used for chemotherapy for 20 weeks. She was successfully treated with thrombolysis, angioplasty and stent placement. The patient died 7 months later due to the underlying disease. Long term catheters are the responsible for 20 to 30% of superior vena cava syndromes. Endovascular treatment of the syndrome is successful in 60 to 100% of cases with a symptomatic relapse in 4 to 45% of patients. (Rev Méd Chile 2001; 129: 421-6)